| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |